SWM
AZN icon

Sanctuary Wealth Management’s AstraZeneca AZN Stock Holding History

Sanctuary Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18
Closed -$2.44K – 263
2024
Q1 		$2.44K Hold
18
– – ﹤0.01% 194
2023
Q4 		$2.42K Hold
18
– – ﹤0.01% 203
2023
Q3 		$2.44K Hold
18
– – ﹤0.01% 191
2023
Q2 		$2.58K Buy
+18
New +$2.65K ﹤0.01% 192
2022
Q4 		$2.44K Buy
+18
New +$2.26K ﹤0.01% 180

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sanctuary Wealth Management's AZN Position: Q2 2024 in Review

Sanctuary Wealth Management sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 18 shares — an estimated $2.44K sold.

Sanctuary Wealth Management first reported a position in AZN in Q4 2022 and held it in 5 quarters. The position peaked at $2.58K in Q2 2023. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • Sanctuary Wealth Management reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • Sanctuary Wealth Management sold 18 AstraZeneca shares in Q2 2024, an estimated $2.44K.
  • Sanctuary Wealth Management first reported a position in AstraZeneca in Q4 2022 and held it in 5 quarters.
  • Sanctuary Wealth Management's AstraZeneca position peaked at $2.58K in Q2 2023.
  • 1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Sanctuary Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.